The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 14, 2021

Filed:

Feb. 12, 2019
Applicant:

Algamed Therapeutics (A.m.t) Ltd, Rosh Pina, IL;

Inventor:

Ronnie Klein, Haifa, IL;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/737 (2006.01); A61P 15/02 (2006.01); C08B 37/00 (2006.01); A61K 36/04 (2006.01); A61K 45/06 (2006.01); A61K 31/352 (2006.01); A61K 31/4745 (2006.01); A61K 47/36 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 31/353 (2006.01); A61K 31/7028 (2006.01); A61K 36/03 (2006.01); A61K 36/05 (2006.01); A61K 36/22 (2006.01); A61K 36/23 (2006.01); A61K 36/28 (2006.01); A61K 36/42 (2006.01); A61K 36/45 (2006.01); A61K 36/48 (2006.01); A61K 36/53 (2006.01); A61K 36/537 (2006.01); A61K 36/55 (2006.01); A61K 36/752 (2006.01); A61K 36/82 (2006.01); A61K 36/87 (2006.01); A61K 36/886 (2006.01); A61K 47/12 (2006.01); A61K 47/22 (2006.01); A61K 47/26 (2006.01); A61K 47/32 (2006.01); A61K 47/42 (2017.01);
U.S. Cl.
CPC ...
A61K 31/737 (2013.01); A61K 9/0034 (2013.01); A61K 9/06 (2013.01); A61K 31/352 (2013.01); A61K 31/353 (2013.01); A61K 31/4745 (2013.01); A61K 31/7028 (2013.01); A61K 36/03 (2013.01); A61K 36/04 (2013.01); A61K 36/05 (2013.01); A61K 36/22 (2013.01); A61K 36/23 (2013.01); A61K 36/28 (2013.01); A61K 36/42 (2013.01); A61K 36/45 (2013.01); A61K 36/48 (2013.01); A61K 36/53 (2013.01); A61K 36/537 (2013.01); A61K 36/55 (2013.01); A61K 36/752 (2013.01); A61K 36/82 (2013.01); A61K 36/87 (2013.01); A61K 36/886 (2013.01); A61K 45/06 (2013.01); A61K 47/12 (2013.01); A61K 47/22 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01); A61K 47/36 (2013.01); A61K 47/42 (2013.01); A61P 15/02 (2018.01); C08B 37/006 (2013.01);
Abstract

Disclosed is a composition for intravaginal and/or for internal mucosal application, comprising an effective amount of a sulfated polysaccharide, one or more of a natural quaternary polymer, a quaternary molecular compound, a metalloproteinase inhibitor, one or more anti-inflammatory agent, an acid pH control buffering system or any combination thereof, and a pharmaceutically acceptable carrier. Further disclosed is a method of treating or alleviating vaginal infection, vaginal dryness, vaginal or vulvo vaginal atrophy, vaginal itching, dyspareunia, vaginal or vulvar pain, vaginal or perivaginal inflammation or for promoting vaginal or wound healing, vaginal atrophy/dryness caused by radiotherapy, chemotherapy and/or hormonal treatment and decreased vaginal boundary lubrication or a disease or condition associated therewith or of improving vaginal boundary lubrication.


Find Patent Forward Citations

Loading…